Brooklyn ImmunoTherapeutics, Inc. announced that on September 20, 2021, Roger Sidhu was granted a non-qualified stock option covering 161,300 shares of Brooklyn’s common stock and a restricted stock unit covering 80,650 shares of Brooklyn’s common stock.
September 23, 2021
· 2 min read